Skip to content

The CareNET trial: Caring for carers of people with advaNced cancer at hospiTal discharge

Caring for carers of people with advaNced cancer at hospiTal discharge (CareNET): A single-arm open label feasibility study.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12622001325796
Acronym
CareNET (Caring for carers of people with advaNced cancer at hospiTal discharge )
Enrollment
5
Registered
2022-10-12
Start date
2022-11-16
Completion date
2023-06-29
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

CareNET is an intervention that is integrated into existing discharge processes and uses the Carer Support Needs Assessment Tool- Intervention (CSNAT-I) to identify and meet the carers needs preparing for the person they care for to return home from hospital. This study aims to determine whether it is feasible to deliver the CSNAT-I to carers both in the hospital setting and in the first few days when they person they care for returns home. Who is it for? You may be eligible for this study if you identify as a carer for someone who has advanced cancer. For this study a carer is someone who is in a close supportive role who share in the illness experience of the patient and who undertake vital care work and emotion management for the patient. Patients with advanced cancer who are currently in-patients at a specialist cancer centre will also be invited to participate. Study details Patients who choose to participate in this study will be asked to meet with an occupational therapist to determine their needs related to achieving discharge home. While the patient is still in hospital, carers who choose to participate in this study will also be asked to meet with the occupational therapist (OT) to identify and prioritise their caring needs using the CSNAT-I tool. Following this initial assessment, the OT will meet again with the carer to develop an action plan for prioritised needs prior to the patient being discharged. Within 3- 7 days after the patient has been discharged home, the carer and OT will review and discuss whether the identified needs have been addressed, including review of any new needs identified by or referring to relevant service providers (e.g., GP, community palliative care service, nurse coordinators). It is anticipated that these meetings may occur face-to-face or via video- or teleconference per the carer's preference. Meetings should take no more than 30-40 minutes. Carers and patients will be asked to complete a series of surveys regarding their experience with the intervention and their health, they may also be asked to participate in a one-on-one interview with a member of the research team to discuss their experiences of the study. It is hoped this research will determine whether it is feasible to deliver the CSNAT-I intervention to carers of patients with advanced cancer. This includes understanding what is required to conduct a larger trial that can test how effective it is in benefiting the patients and carers and how we can translate it into everyday practice. The results of the larger trial may then lead to improved health and wellbeing for future carers and patients.

Interventions

What: Materials: The Carer Support Needs Assessment Tool - Intervention (CSNAT-I) tool will be used. This is a licensed tool that can be found at www.csnat.org. It consists of 14 domains of need for carer of people with palliative care needs. It is part of the CSNAT-I – a five stage carer-led, clinician facilitated intervention that was developed in the UK and has been validated with community-based carers for people with advanced cancer. This paper-based form is a record that carers can keep a

What: Materials: The Carer Support Needs Assessment Tool - Intervention (CSNAT-I) tool will be used. This is a licensed tool that can be found at www.csnat.org. It consists of 14 domains of need for carer of people with palliative care needs. It is part of the CSNAT-I – a five stage carer-led, clinician facilitated intervention that was developed in the UK and has been validated with community-based carers for people with advanced cancer. This paper-based form is a record that carers can keep and clinicians’ document summary in the electronic medical record. Online learning modules were used to train intervention providers and can be found at the website once license is approved. A local protocol was developed and will be used to assist with intervention delivery and documentation into electronic medical record. Procedures: The intervention includes identification and prioritisation of needs (Stages 1-3); Development of action plan for prioritised needs (Stage 4); and review of whether needs have been addressed; and structured handover of outstanding needs (Stage 5). Needs Assessment After the Occupational Therapist (OT) has completed an initial assessment with patients to determine their needs related to achieving discharge home (e.g., functional limitations, physical care needs, QOL of goals); they meet with the carer to identify and prioritise their discharge needs using the CSNAT-I paper based tool (Stages 1-3). This can occur face to face, via telehealth or the phone depending on carer preference and access. The assessment process involves carers being provided with the 14 domains of need, self-rating how much support they think they need and describing how the need relates to them. For example, the domain “needing help with equipment” may relate to a carer wanting to know how to use a manual lifting device. The carer will then choose three needs they have described that they wish to prioritise and seek support with before discharge home. Responding to needs: The OT identifies with the carer what actions are required to address prioritised needs (Following Stage 4 of CSNAT-I). Actions that need to be communicated to the patient and team is determined between OT and carer at this stage. Actions may be direct OT intervention, referrals to other disciplines and providers; signposted for carers to address themselves or self-directed exclusively by the carer. These are documented on the CSNAT-I which both the carer and OT keep copies of. The OT actions the relevant items within the required time. A pre-discharge review will occur if needed by carer e.g., to check they have all the equipment delivered to their house. Proposed and enacted action plans are communicated to the patient and team members as required. Review: Prior to discharge the OT will ask the carer to nominate the preferred method and time of review required after discharge. Options will be (1) treating OT to phone at time proposed by carer; (2) other key contact identified by carer (social worker, nurse coordinator) or (3) carer contacts treating OT or key contact person at preferred time. Shared review (Stage 5 CSNAT-I) will involve (1) checking if action plan has been completed, and (2) addressing outstanding or new needs identified by or referring to relevant service providers (e.g., GP, community palliative care service, nurse coordinators). Who: Trained occupational therapists will facilitate the delivery of the CSNAT-I aspect of the intervention. Multi-disciplinary interventions will be delivered (in response to CSNAT-I) based on individual need. How: Stages 1 to 4 will be delivered face to face, telehealth or via phone; Stage 5 will be telehealth or via phone. It will occur between the OT and the carer for the patient. Where: Stages 1-4 will occur during acute admission and Stage 5 will occur once the patient has been discharged from the acute hospital. Treating occupational therapists delivering the intervention will be based in the hospital however there may be circumstances where they are conducting a home visit. When and how much: Stages 1-4 during hospital stay and when discharge home has been decided. Stage 5 within 72 hours after discharge (or other times nominated by carer, but no more than 1 week after discharge). Stage 1-4 can occur as separate or combined contacts between OT and carer. It is anticipated that stages 1-4 will take between 20-40 minutes; and stage 5 between 5 -20 minutes. However this will depend on individual needs and whether it is occurring within other bundles of care e.g. psychoeducation. If the person with advanced cancer has a change in planned discharge destination, anticipated care needs, length of stay in hospital; different stages of the intervention can be repeated Tailoring A person-centred model means actions and care generated from the intervention and how it is delivered is individualised and based on personal needs. Strategies used to monitor adherence will include: record of participation rates, outputs from intervention and completion of tool; check points for clinicians to ensure fidelity and completion rates.

Sponsors

Peter MacCallum Cancer Centre
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Carer participants must meet the inclusion criteria in order for patient participants to be included. Carer inclusion criteria • Must identify as carer. This study will refer to a carer as “Lay people in a close supportive role who share in the illness experience of the patient and who undertake vital care work and emotion management” (2) • Able to provide informed consent • English speaking and able to read at 5th grade level Patient inclusion criteria - Diagnosis of advanced cancer - Must have a person (family member or friend) that identifies as their carer - Planned discharge home - English-speaking - Able to provide informed consent or person consenting on participants behalf (authorized representative) * *Patients providing own consent will complete all measures, patients consenting via authorised representative will not complete self-rating measures (Quality of Life (EQSD)and Survey on costs) Clinician inclusion criteria • Occupational therapist delivering the intervention during the trial. Process for identifying an authorised representative for patient If the participant is not able to provide consent, the authorised representative will be identified and approached for consent to participate. As defined by the Health Records Act – Section 85, the authorised representative (the individual who can make decisions regarding consent to use and disclose health information) can be one of the following: a. A guardian of the individual; or b. An attorney for the individual under an enduring power of attorney; or c. The individual medical treatment decision maker within the meaning of the Medical Treatment Planning and Decisions Act 2016; or d. An administrator within the meaning of the Guardianship and Administration Act 2019; or e. A parent of the individual if the individual is a child; or f. Otherwise empowered under law to perform duties or exercise powers in the best interests of the individual

Exclusion criteria

Participants who meet any of the following criteria will be excluded from study entry: Patient exclusion criteria - Planned discharge to residential care or subacute.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026